Share Buyback

In a major strategic pivot, Elkem will trade its Silicones division to Bluestar in exchange for its majority stake, reshaping the firm into a focused metals company.

Legrand's plan to repurchase 250,000 shares goes beyond pure financials, signaling a strategic investment in its workforce amid a competitive market.

The aviation firm renews its share buyback program, a move backed by a stronger balance sheet and a strategic pivot to higher-margin services.

The newly rebranded firm touts record fundraising and a key acquisition, but declining non-GAAP earnings reveal a more complicated financial reality for investors.

Aircraft leasing giant Avolon posts record profits, capitalizing on soaring travel demand and severe aircraft shortages plaguing global airlines.

The insurer's double-digit dividend hike follows a year of record core earnings, rewarding shareholders and showcasing its robust financial health.

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

Amid a surging aerospace market, StandardAero's upcoming earnings report is highly anticipated after a year of record growth and strategic expansion.

After a stock plunge, Yext offers to buy back shares at a premium, signaling deep undervaluation and creating a critical choice for its investors.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

Freya Investissement is boosting its economic stake in Tele2 to 27% via swaps, signaling a major consolidation of power by its influential backer, Xavier Niel.

With its stock soaring, AGF Management renews its buyback plan to repurchase 10% of its public float, a strategic move to boost value and manage dilution.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

Barrick Mining unveils a massive dividend hike and a new cash-return policy, but a surprising market dip raises questions about its future outlook.

The South Korean tobacco giant hits record revenue as its international strategy pays off, while it diversifies into nicotine pouches for future growth.

Mount Logan Capital's tender offer was met with high demand, leading to a planned 12% reduction in shares and boosting key per-share metrics.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

CDW announces a $0.630 quarterly dividend, marking 12 straight years of increases. Discover how its robust capital strategy fuels consistent investor returns.